Placebo (n = 19) | Q10-300 (n = 23) | Pvalues1 | |
---|---|---|---|
Male / female (n) | 12 / 7 | 19 / 4 | 0.180a |
Age (y) | 66.5 ± 11.1 (68.0) | 71.7 ± 11.5 (72.0) | 0.148b |
SBP (mmHg) | 133.6 ± 6.9 (130.0) | 131.8 ± 12.0 (130.0) | 0.175c |
DBP (mmHg) | 75.5 ± 5.2 (74.0) | 73.8 ± 7.1 (70.0) | 0.234c |
Waist circumference (cm) | 95.2 ± 10.0 (96.0) | 92.1 ± 11.3 (90.0) | 0.362b |
Waist hip ratio | 1.0 ± 0.1 (0.9) | 0.9 ± 0.1 (0.9) | 0.743b |
BMI (kg/m2) | 26.7 ± 3.2 (26.5) | 25.9 ± 3.5 (25.3) | 0.438b |
Current smoker2, n (%) | 4 (21.1%) | 1 (4.3%) | 0.158d |
Drink alcohol3, n (%) | 2 (10.5%) | 3 (13.0%) | 1.000a |
Exercise4, n (%) | 13 (68.4%) | 15 (65.2%) | 0.913d |
Creatinine (μmol/L) | 123.8 ± 70.7 (106.1) | 114.9 ± 44.2 (97.2) | 0.780c |
TC (mmol/L) | 4.5 ± 1.3 (4.4) | 5.0 ± 1.0 (4.9) | 0.175b |
TG (mmol/L) | 1.7 ± 1.3 (1.3) | 1.6 ± 0.9 (1.4) | 0.791c |
LDL-C (mmol/L) | 2.7 ± 0.8 (2.5) | 3.0 ± 0.8 (3.1) | 0.165b |
HDL-C (mmol/L) | 1.4 ± 0.4 (1.4) | 1.4 ± 0.3 (1.4) | 0.984b |